• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.27% Nasdaq Down0.19%

    Anthera Pharmaceuticals, Inc. (ANTH)

    -NasdaqGM
    10.71 Up 0.28(2.68%) Aug 4, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 245   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 245   -   -   -  
    Operating Expenses
    Research Development5,995  5,527  5,268  5,279  
    Selling General and Administrative1,907  1,771  1,419  1,586  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (7,657) (7,298) (6,687) (6,865)
    Income from Continuing Operations
    Total Other Income/Expenses Net(3)(3)(14)(31)
    Earnings Before Interest And Taxes(7,660)(7,301)(6,701)(6,896)
    Interest Expense -  144  286  360  
    Income Before Tax(7,660)(7,445)(6,987)(7,256)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(7,660)(7,445)(6,987)(7,256)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,660) (7,445) (6,987) (7,256)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,660) (7,445) (6,987) (7,256)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.